ESRD (END STAGE RENAL DISEASE)
Clinical trials for ESRD (END STAGE RENAL DISEASE) explained in plain language.
Never miss a new study
Get alerted when new ESRD (END STAGE RENAL DISEASE) trials appear
Sign up with your email to follow new studies for ESRD (END STAGE RENAL DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to tame dangerous mineral in kidney patients
Disease control CompletedThis study tested a new drug called AP301 to see if it works as well as or better than a standard medication (sevelamer) at controlling high phosphorus levels in the blood of people on long-term dialysis. It involved 474 Chinese adults with chronic kidney disease who were receivi…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New device tested to help dialysis patients
Diagnosis CompletedThis small, completed pilot study tested a new device called HemoCept. The goal was to see if the device's readings matched changes in a patient's fluid weight during their dialysis treatment. It involved 12 adults with end-stage kidney disease to check if the device could accura…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Sponsor: HemoCept Inc. • Aim: Diagnosis
Last updated Mar 30, 2026 14:32 UTC
-
AI could give doctors early warning for dialysis complications
Knowledge-focused CompletedThis study looked at whether an artificial intelligence (AI) system could help monitor people on long-term kidney dialysis. Researchers analyzed past medical records from 778 patients to build computer models. The goal is to create a tool that spots early signs of problems like h…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
New device tested to track fluid in dialysis patients
Knowledge-focused CompletedThis small, completed study tested a new device called HemoCept. Researchers wanted to see if the device's readings matched the actual amount of fluid removed from patients during their dialysis treatments. The study also checked if the device was safe to use and if a person's sk…
Matched conditions: ESRD (END STAGE RENAL DISEASE)
Sponsor: HemoCept Inc. • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:27 UTC